Clinical Trial Update: Safety, Tolerability, and Biodistribution of [89Zr]Zr-DFO-APAC in Subjects With PAOD/CLI and Healthy Volunteers (Acronyms: 89Zr = Zirconium-89, DFO = Desferrioxamine, APAC = AntiPlatelet AntiCoagulant, PET/CT = Positron Emission Tomography/Computed Tomography) [EARLY_Phase 1]

View source ↗

Summary

Early-phase clinical trial update evaluating safety, tolerability, and biodistribution of the Zirconium-89–labeled tracer [89Zr]Zr-DFO-APAC in patients with per…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Critical Limb Ischemia
• Peripheral Arterial Occlusive Disease

Drugs mentioned

• [89Zr]Zr-DFO-APAC (Zirconium-89-labeled DFO-APAC tracer)

Snippet

Sponsor: Aplagon Oy | Conditions: Peripheral Arterial Occlusive Disease, Critical Limb Ischemia | EARLY_Phase 1 | Status: RECRUITING